Canopy Growth Corporation

TSX:WEED.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.72 +2.26%

+$0.03 today

Market cap
$323.72M
Beta
2.41
P/E (TTM)
-1.8
EPS (TTM)
-$0.76
52W Low $1.18High $3.28

Volume 1.16M

Average 2.07M

WEED.TO Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Canopy Growth CorporationTSX: WEED.TO

Gross Profit · Q4 FY2025 · quarter ended Mar 2026

Gross profit declines year over year

Q4 FY2025 gross profit of CA$8.26M fell 21.7% year over year, behind the -7.5% change in trailing-twelve-month gross profit. Sequentially, it fell 50.5% from the prior quarter.

Context

  • Gross profit amounted to 24.5% of revenue in FY2025, down 5.1 pp from a year earlier.
  • Gross profit increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -21.7% toward the trailing-twelve-month pace of -7.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$8.26M-50.5% QoQ
Last fiscal yearMar 2026
CA$69.67M-12.4% YoY
LTMMar 2026
CA$73.53M-7.5% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-21.7%——
1 year-12.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Gross Profit history

CAD · from the income statement

Latest · FY2025
69.67M CAD
Year-over-year change
-12.4%

Gross Profit vs competitors

How WEED.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -7.5% is the 4th highest of 8, against a peer median of -10.0%.
  • Gross profit amounts to 23.6% of revenue for WEED.TO, versus a peer median of 50.9%.
WEED.TO Competitors
Gross Profit for WEED.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TSND.TOTerrAscend Corp.LTM Mar 2026$133.27M USD-10.0%+3.6%50.9%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$100.28M CAD-46.5%—31.5%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$75.4M CAD+9.0%+73.8%47.5%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$73.53M CAD-7.5%—23.6%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$47.19M USD+69.1%+204.4%92.2%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$37.95M USD+33.5%+26.5%74.5%
EDT.TOSpectral Medical Inc.LTM Mar 2026-CA$2.19M CAD-303.3%—79.2%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-CA$8.41M CAD-113.3%—3.1%
Peer median (excluding WEED.TO) —-10.0%+50.2%50.9%

Competitors are the stored peer set for WEED.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue475.7M333.25M297.15M269M284.6M
Cost of Revenue653.93M431.64M216.26M189.48M214.93M
Gross Profit(143.6M)(98.38M)80.88M79.51M69.67M
Gross Margin-30.2%-29.5%27.2%29.6%24.5%
Research & Development32.26M21.72M4.61M2.74M0
Selling, General & Admin361.1M297.98M175.98M121.71M122.93M
Operating Expenses445.08M297.4M309.6M196.65M142.78M
Depreciation & Amortization110.94M80.03M53.18M43.12M36.47M
EBITDA(52.98M)(2.88B)(312.83M)(479.31M)(188.22M)
EBITDA Margin-11.1%-864.2%-105.3%-178.2%-66.1%
Operating Income(588.69M)(395.78M)(228.71M)(117.14M)(73.11M)
Operating Margin-123.8%-118.8%-77.0%-43.5%-25.7%
Interest Income6.6M24.28M16.24M8.82M10M
Interest Expense103.94M126.16M105.35M74.57M38.19M
Other Income / Expenses370.63M(2.69B)(242.64M)(479.85M)(189.78M)
Income Before Tax(267.86M)(3.09B)(471.36M)(597M)(262.89M)
Pre-Tax Margin-56.3%-926.1%-158.6%-221.9%-92.4%
Income Tax Expense(8.95M)(5.73M)12.33M7.14M23K
Net Income(310.04M)(3.28B)(657.27M)(598.12M)(262.91M)
Net Margin-65.2%-983.7%-221.2%-222.4%-92.4%
EPS (Basic)(0.81)(12.18)(8.79)(5.56)(0.76)
EPS (Diluted)(0.81)(12.18)(8.79)(5.56)(0.76)
Weighted Avg Shares396.1M271.61M74.79M107.55M345.53M
Weighted Avg Shares (Diluted)396.36M271.61M74.79M107.55M345.53M

Canopy Growth Corporation

TSX:WEED.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.